RankAlpha logo
Back to Rankings

TMCI

Treace Medical ConceptsC
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
View Chart
Current thesis
The constructive setup is that Treace has already cut cash usage materially, guided to another roughly 50% reduction in 2026 cash usage, posted a preliminary Q1 cash increase, and now has identifiable launch hooks in SuperBite and SpeedXM that could improve surgeon wallet share if execution is clean. [#8-K-2026-04-09] [#PR-2026-04-07]
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Commercial execution risk increased after the April 8, 2026 chief commercial officer departure disclosed in the 8-K.
Momentum
89
Value
36
Sentiment
24
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.20 · Bull $3.80 · Bear $1.30
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $5.05
Why
Momentum89 · Δ7d -
Value36 · Δ7d -0.0
Sentiment24 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
89
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
24
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade C. Momentum 89.0 / Value 36.4 / Sentiment 23.9

Fundamentals (TTM)
As of 2026-06-02
Market Cap
$225.11M
Beta
0.74
Shares Out
63.72M
P/E (TTM) · Derived
-3.8
P/S (TTM)
0.77
P/FCF (TTM) · Derived
-8.43
Rev YoY
+11.4%
EPS YoY
-3.9%
Gross Margin
+79.9%
Op Margin
-22.1%
Net Debt
-$22.37M
Current Ratio
3.37
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology